Product Name: Bydureon® BCise (Exenatide) 2 mg
Presentation: Pack containing 4 single-dose prefilled pens for subcutaneous injection. Each pen delivers 2 mg of exenatide in an extended-release formulation designed for once-weekly administration.
Visual Description
- Branded pharmaceutical carton in a blue-and-white color scheme.
- Front panel typically displays:
- BYDUREON® BCise
- Exenatide 2 mg
- Prolonged-release suspension for injection
- 4 prefilled pens
- Once-weekly dosing
- Inside the carton are 4 single-use prefilled injection pens, each intended for one weekly dose.
Product Information
- Active ingredient: Exenatide 2 mg
- Drug class: GLP-1 receptor agonist
- Indication: Treatment of Type 2 Diabetes Mellitus to improve glycemic control alongside diet, exercise, and other glucose-lowering therapies when appropriate.
- Recommended dosage: 2 mg once weekly.
Packaging Contents
- 4 Ă— single-dose prefilled pens
- Each pen contains a complete weekly dose
- For subcutaneous injection in the abdomen, thigh, or upper arm as directed by a healthcare professional.
Catalog Alt Text
“BYDUREON BCise Exenatide 2 mg prolonged-release suspension for injection, pack of four single-use prefilled pens in a blue-and-white AstraZeneca carton for once-weekly management of Type 2 diabete
Be the first to review “BYDUREON Exenatidum 2 mg, 4 preffiled pens”
Reviews
There are no reviews yet.